Cargando…

Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease

BACKGROUND & AIMS: Thrombospondin 1 (TSP1) is a multifunctional matricellular protein. We previously showed that TSP1 has an important role in obesity-associated metabolic complications, including inflammation, insulin resistance, cardiovascular, and renal disease. However, its contribution to o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gwag, Taesik, Reddy Mooli, Raja Gopal, Li, Dong, Lee, Sangderk, Lee, Eun Y., Wang, Shuxia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689554/ https://www.ncbi.nlm.nih.gov/pubmed/33294831 http://dx.doi.org/10.1016/j.jhepr.2020.100193

Ejemplares similares

Thrombospondin1 antagonist peptide treatment attenuates obesity-associated chronic inflammation and metabolic disorders in a diet-induced obese mouse model
por: Zhou, Qi, et al.
Publicado: (2023)

Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease
por: Mooli, Raja Gopal Reddy, et al.
Publicado: (2022)

Rebuttal to: Inflammation: The Straw That Broke the NAFLD Liver!
por: Mooli, Raja Gopal Reddy, et al.
Publicado: (2022)

Liver Steatosis is a Driving Factor of Inflammation
por: Mooli, Raja Gopal Reddy, et al.
Publicado: (2022)

CD47 antisense oligonucleotide treatment attenuates obesity and its-associated metabolic dysfunction
por: Gwag, Taesik, et al.
Publicado: (2023)

Hypoxia via ERK Signaling Inhibits Hepatic PPARα to Promote Fatty Liver
por: Mooli, Raja Gopal Reddy, et al.
Publicado: (2021)

A study of non-alcoholic fatty liver disease-liver fat score in overweight and obese individuals
por: Koneru, Kavya, et al.
Publicado: (2022)

Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism
por: Lefere, Sander, et al.
Publicado: (2019)

Endothelial-derived thrombospondin-1 promotes macrophage recruitment and apoptotic cell clearance
por: Kirsch, Torsten, et al.
Publicado: (2010)

Expression data on liver metabolic pathway genes and proteins
por: Raja Gopal Reddy, Mooli, et al.
Publicado: (2016)

Thrombospondin1 Deficiency Attenuates Obesity-Associated Microvascular Complications in ApoE-/- Mice
por: Maimaitiyiming, Hasiyeti, et al.
Publicado: (2015)

Macrophages and scavenger receptors in obesity‐associated non‐alcoholic liver fatty disease (NAFLD)
por: Kragh Petersen, Sine, et al.
Publicado: (2020)

Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases
por: Park, Ji-Won, et al.
Publicado: (2021)

Thrombospondin1 Deficiency Reduces Obesity-Associated Inflammation and Improves Insulin Sensitivity in a Diet-Induced Obese Mouse Model
por: Li, Yanzhang, et al.
Publicado: (2011)

Thrombospondin1 as a potential therapeutic target for human nonalcoholic fatty liver disease
por: Song, Yongfeng, et al.
Publicado: (2020)

Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
por: Kim, Hong-Kyu, et al.
Publicado: (2023)

Hepatic ketogenesis regulates lipid homeostasis via ACSL1-mediated fatty acid partitioning
por: Ramakrishnan, Sadeesh, et al.
Publicado: (2023)

Imatinib reduces non-alcoholic fatty liver disease in obese mice by targeting inflammatory and lipogenic pathways in macrophages and liver
por: AlAsfoor, Shefaa, et al.
Publicado: (2018)

Environmental conditioning in the control of macrophage thrombospondin-1 production
por: Fordham, Jezrom B., et al.
Publicado: (2012)

Macrophages and the development and progression of non-alcoholic fatty liver disease
por: Alabdulaali, Bader, et al.
Publicado: (2023)

Thrombospondin 1 Deficiency Ameliorates the Development of Adriamycin-Induced Proteinuric Kidney Disease
por: Maimaitiyiming, Hasiyeti, et al.
Publicado: (2016)

Association between non-alcoholic fatty liver disease and coronary calcification depending on sex and obesity
por: Kim, Seok-hyung, et al.
Publicado: (2020)

Liver macrophages and inflammation in physiology and physiopathology of non‐alcoholic fatty liver disease
por: Thibaut, Ronan, et al.
Publicado: (2021)

Carrot Juice Administration Decreases Liver Stearoyl-CoA Desaturase 1 and Improves Docosahexaenoic Acid Levels, but Not Steatosis in High Fructose Diet-Fed Weanling Wistar Rats
por: Mahesh, Malleswarapu, et al.
Publicado: (2016)

Thrombospondin-1 triggers macrophage IL-10 production and promotes resolution of experimental lung injury
por: Zhao, Yani, et al.
Publicado: (2013)

HIV Protein Tat Induces Macrophage Dysfunction and Atherosclerosis Development in Low-Density Lipoprotein Receptor-Deficient Mice
por: Meng, Zhaojie, et al.
Publicado: (2022)

Pediatric Fatty Liver and Obesity: Not Always Just a Matter of Non-Alcoholic Fatty Liver Disease
por: Alfani, Renata, et al.
Publicado: (2018)

Thrombospondins and synaptogenesis★
por: Wang, Bin, et al.
Publicado: (2012)

Effects of thrombospondin-4 on pro-inflammatory phenotype differentiation and apoptosis in macrophages
por: Rahman, Mohammed Tanjimur, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease and liver secretome
por: Khan, Muhammad Sohaib, et al.
Publicado: (2022)

Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH)
por: Min-DeBartolo, Jessica, et al.
Publicado: (2019)

GLP-1 Receptor Agonist and Non-Alcoholic Fatty Liver Disease
por: Lee, Jinmi, et al.
Publicado: (2012)

Role of thrombospondin-1 and thrombospondin-2 in cardiovascular diseases (Review)
por: Zhang, Kaijie, et al.
Publicado: (2020)

Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack
por: Oates, Jarren R., et al.
Publicado: (2019)

Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis
por: Ni, Yinhua, et al.
Publicado: (2016)

Thrombospondin is an osteoblast-derived component of mineralized extracellular matrix
Publicado: (1989)

Thyroid Function in Obese Children with Non-Alcoholic Fatty Liver Disease
por: Bilgin, Hüseyin, et al.
Publicado: (2014)

Hepcidin in morbidly obese women with non-alcoholic fatty liver disease
por: Auguet, Teresa, et al.
Publicado: (2017)

The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity
por: Van Herck, Mikhaïl A., et al.
Publicado: (2019)

Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease
por: Zhou, Mimi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_krt1d73pfb6m5m5fj52l1b8qv1